Last update 01 Nov 2024

The Asan Foundation

Private Company|
1977|
Seoul, South Korea
|
www.asanfoundation.or.kr

Overview

Tags

Neoplasms
Digestive System Disorders
Respiratory Diseases
Monoclonal antibody
Recombinant polypeptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Top 5 Drug TypeCount
Monoclonal antibody2
Recombinant polypeptide1
Top 5 TargetCount
SOD1(Superoxide dismutase)1
LGALS3BP(galectin 3 binding protein)1
V-set domain containing1

Related

5
Drugs associated with The Asan Foundation
[18F]THK-5351
Target
TAU
Mechanism
TAU inhibitors [+1]
Active Org.
Chang Gung Memorial Hospital
Originator Org.
Tohoku UniversityTohoku University
Active Indication
Neuroinflammation
Inactive Indication
Alzheimer Disease [+4]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
BAY-94-9392
Target
SLC7A11
Mechanism
SLC7A11 inhibitors [+1]
Active Org.
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center [+6]
Originator Org.
Piramal Pharma Limited
Active Indication
Allograft Rejection [+12]
Inactive Indication
Advanced Triple-Negative Breast Carcinoma [+18]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
KR1020220014818
Patent Mining
Target
V-set domain containing
Mechanism-
Active Org.
University of Ulsan Foundation for Industry Cooperation [+1]
Originator Org.
The Asan Foundation [+1]
Active Indication
Gastrointestinal Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
3
Clinical Trials associated with The Asan Foundation
NCT03546868 / CompletedPhase 2IIT
Phase 2, Open-label, Non-randomized, Single Center Study to Explore Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Subjects With Inflammatory Bowel Disease.
NCT03112096 / CompletedPhase 1IIT
A Phase I [18F]THK-5351 Positron Emission Computed Tomography Study of Biodistribution, Pharmacokinetics and Safety in Cognitively Healthy Subjects and Patients With Alzheimer's Disease
NCT02864810 / CompletedPhase 1IIT
A Phase 1, Open-label, Non-randomized, Single Center Study to Assess Safety, Pharmacokinetics, Biodistribution, Internal Radiation Dosimetry and Diagnostic Performance of [18F]GP1 Positron Emission Tomography in Subjects With Venous or Arterial Thromboembolism
100 Clinical Results associated with The Asan Foundation
Login to view more data
0 Patents (Medical) associated with The Asan Foundation
Login to view more data
100 Deals associated with The Asan Foundation
Login to view more data
100 Translational Medicine associated with The Asan Foundation
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
3
2
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free